Comments

Iterum Therapeutics (ITRM) Stock Price, Quote, News & History

ITRMNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$0.3891

-0.0129-3.21%

At close: Dec 17, 4:00 PM EST

$0.4038

0.01473.78%

After Hours: 6:27 PM EST

Overview

News Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.40

Close

$0.39

Volume / Avg.

575.39K / 931.83K

Day Range

$0.38 - $0.42

52 Wk Range

0.36 - 2.10

Market Cap

$21.32M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

3.14%

Days to Cover

1.01

Recent Iterum Therapeutics PLC News

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle.

Erica Kollmann

Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?

Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.

Piero Cingari

FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships

Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first approved indication and a U.S. first for oral penems.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$0.40

Close

$0.39

Volume / Avg.

575.39K / 931.83K

Day Range

$0.38 - $0.42

52 Wk Range

0.36 - 2.10

Market Cap

$21.32M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

3.14%

Days to Cover

1.01

About

Sector

Health Care

Industry

Pharmaceuticals

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

Show More

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ:ITRM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Iterum Therapeutics (ITRM) competitors?

A

Other companies in Iterum Therapeutics’s space includes: Cingulate Inc (NASDAQ:CING), Cocrystal Pharma Inc (NASDAQ:COCP), SCYNEXIS Inc (NASDAQ:SCYX), Lipocine Inc (NASDAQ:LPCN) and Tvardi Therapeutics Inc (NASDAQ:TVRD).

Q

What is the forecast, or price target, for Iterum Therapeutics (ITRM) stock?

A

Iterum Therapeutics has a consensus price target of $7.00.

Q

What is the current price for Iterum Therapeutics (ITRM)?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $0.4038 last updated December 17, 2025 at 6:27 PM EST.

Q

Does Iterum Therapeutics (ITRM) pay a dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A

Iterum Therapeutics does not have any upcoming earnings scheduled.

Q

Is Iterum Therapeutics (ITRM) going to split?

A

There is no upcoming split for Iterum Therapeutics.

Q

What sector and industry does Iterum Therapeutics (ITRM) operate in?

A

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Cocrystal Pharma Inc

Tvardi Therapeutics Inc

Traws Pharma Inc

Cadrenal Therapeutics Inc

Vyome Holdings Inc